dalteparin has been researched along with Placenta Praevia in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of pulmonary embolism successfully treated with low molecular weight heparin in a woman with a major grade placenta praevia, who required emergency operative delivery." | 1.30 | Thromboembolism treated with low molecular weight heparin in a pregnancy complicated by major placenta praevia: a case report. ( Hertzberg, M; Lahoud, R; Nicholl, M; Rowlands, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rowlands, S | 1 |
| Lahoud, R | 1 |
| Hertzberg, M | 1 |
| Nicholl, M | 1 |
1 other study available for dalteparin and Placenta Praevia
| Article | Year |
|---|---|
Thromboembolism treated with low molecular weight heparin in a pregnancy complicated by major placenta praevia: a case report.
Topics: Adult; Cesarean Section; Dalteparin; Female; Humans; Male; Molecular Weight; Placenta Previa; Pregna | 1997 |